본문 바로가기
KERD
논문KCI 등재

Ruptured Peripheral Cerebral Aneurysms Associated With Moyamoya Disease: A Systematic Review

Zheng Feng|Yongquan Chang|Chao Fu
대한뇌졸중학회 (The Korean Stroke Society)|2024.09|대한뇌졸중영문학회지 (Journal of stroke)|제26권 제3호|pp. 360-370

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

Risk factorSystematic reviewTreatmentOutcomeMoyamoya diseaseAneurysm
주제분류신경과학

초록

A ruptured peripheral cerebral aneurysm (PPCA) associated with moyamoya disease (MMD) is a rare but potentially life-threatening condition with controversial management strategies. To summarize the clinical characteristics, treatment strategies, and prognostic factors of PPCAs in MMD, we reviewed studies published in PubMed between 1980 and 2023 and used logistic regression analysis to identify the risk factors for adverse outcomes. Of 425 identified studies, 48 eligible studies involving 121 participants were included in the current study. The mean age at diagnosis was 40.8±15.1 years, with a peak age of onset between 41 and 50 years. Among the identified participants, 59.6% were female, and 55.9% presented with impaired consciousness. Aneurysms were present in the posterior (35.5%) or anterior (30.6%) choroidal arteries in 66.1% of the cases, and 71.1% of the patients presented with intraventricular hemorrhage (IVH) with or without intracerebral hematoma (ICH). The treatment strategies were embolization (28.9%), direct surgery (21.5%), revascularization (22.3%), and conservation (27.3%). Favorable outcomes were achieved in 86.8% of all cases, with 97.1% for embolization, 65.4% for direct surgery, 96.3% for revascularization, and 84.8% for conservative treatment. Aneurysm rebleeding occurred in 11 (26.8%) of 41 patients managed conservatively, leading to worse outcomes in 7 patients (63.6%). Impaired consciousness (odds ratio [OR], 8.61; 95% confidence interval [CI], 2.06–36.00) and aneurysm rebleeding (OR, 16.54; 95% CI, 3.08–88.90) independently predicted poor outcomes. In conclusion, PPCA should be considered in patients with hemorrhagic MMD, particularly those with IVH with or without ICH. Endovascular and bypass treatments are recommended as first-line options, with direct open surgery as an alternative in urgent hematoma evacuation cases. Detailed preoperative planning and intraoperative technical assistance are necessary to reduce procedurerelated complications. Conservative management should be selected with caution because of the high risk of rebleeding and poor outcomes. Impaired consciousness and aneurysm rebleeding appeared to be independent risk factors for adverse prognoses. We emphasize that treatment selection should be personalized, and the potential benefits should be weighed against the associated risks.

Abstract

A ruptured peripheral cerebral aneurysm (PPCA) associated with moyamoya disease (MMD) is a rare but potentially life-threatening condition with controversial management strategies. To summarize the clinical characteristics, treatment strategies, and prognostic factors of PPCAs in MMD, we reviewed studies published in PubMed between 1980 and 2023 and used logistic regression analysis to identify the risk factors for adverse outcomes. Of 425 identified studies, 48 eligible studies involving 121 participants were included in the current study. The mean age at diagnosis was 40.8±15.1 years, with a peak age of onset between 41 and 50 years. Among the identified participants, 59.6% were female, and 55.9% presented with impaired consciousness. Aneurysms were present in the posterior (35.5%) or anterior (30.6%) choroidal arteries in 66.1% of the cases, and 71.1% of the patients presented with intraventricular hemorrhage (IVH) with or without intracerebral hematoma (ICH). The treatment strategies were embolization (28.9%), direct surgery (21.5%), revascularization (22.3%), and conservation (27.3%). Favorable outcomes were achieved in 86.8% of all cases, with 97.1% for embolization, 65.4% for direct surgery, 96.3% for revascularization, and 84.8% for conservative treatment. Aneurysm rebleeding occurred in 11 (26.8%) of 41 patients managed conservatively, leading to worse outcomes in 7 patients (63.6%). Impaired consciousness (odds ratio [OR], 8.61; 95% confidence interval [CI], 2.06–36.00) and aneurysm rebleeding (OR, 16.54; 95% CI, 3.08–88.90) independently predicted poor outcomes. In conclusion, PPCA should be considered in patients with hemorrhagic MMD, particularly those with IVH with or without ICH. Endovascular and bypass treatments are recommended as first-line options, with direct open surgery as an alternative in urgent hematoma evacuation cases. Detailed preoperative planning and intraoperative technical assistance are necessary to reduce procedurerelated complications. Conservative management should be selected with caution because of the high risk of rebleeding and poor outcomes. Impaired consciousness and aneurysm rebleeding appeared to be independent risk factors for adverse prognoses. We emphasize that treatment selection should be personalized, and the potential benefits should be weighed against the associated risks.

참고문헌 (69)

  1. Larson AS, "Location-based treatment of intracranial aneurysms in moyamoya disease : a systematic review and descriptive analysis", Neurosurg Rev, 44, pp.1127~1139 (2021)
  2. Ni W, "Treatment of aneurysms in patients with moyamoya disease : a 10-year single-center experience", J Neurosurg, 128, pp.1813~1822 (2018)
  3. Kim S, "Clinical features and outcomes of intracranial aneurysm associated with moyamoya disease", J Clin Neurol, 16, pp.624~632 (2020)
  4. Yoshida Y, "Clinical course, surgical management, and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage : an extensive follow-up study", Stroke, 30, pp.2272~2276 (1999)
  5. Kim SH, "Endovascular treatment of ruptured aneurysms or pseudoaneurysms on the collateral vessels in patients with moyamoya disease", Neurosurgery, 65, pp.1000~1004 (2009)
  6. Okawa M, "Surgical management of a ruptured posterior choroidal intraventricular aneurysm associated with moyamoya disease", Cent Eur J Med, 8, pp.818~821 (2013)
  7. Kim JH, "Intracranial aneurysms in adult moyamoya disease", World Neurosurg, 109, pp.e175~e182 (2018)
  8. Yamada H, "Short-term spontaneous resolution of ruptured peripheral aneurysm in moyamoya disease", World Neurosurg, 126, pp.247~251 (2019)
  9. Arai Y, "Ruptured intracranial aneurysms associated with moyamoya disease : three case reports", Neurol Med Chir(Tokyo), 51, pp.774~776 (2011)
  10. Ali MJ, "Surgical management of a ruptured posterior choroidal intraventricular aneurysm associated with moyamoya disease using frameless stereotaxy : case report and review of the literature", Neurosurgery, 54, pp.1019~1024 (2004)
  11. Tanaka Y, "Intracranial ruptured aneurysm accompanying moyamoya phenomenon", Acta Neurochir(Wien), 52, pp.35~43 (1980)
  12. Konishi Y, "Aneurysms associated with moyamoya disease", Neurosurgery, 16, pp.484~491 (1985)
  13. Grabel JC, "Moyamoya-like disease associated with a lenticulostriate region aneurysm : case report", J Neurosurg, 70, pp.802~803 (1989)
  14. Hamada J, "Moyamoya disease with repeated intraventricular hemorrhage due to aneurysm rupture : report of two cases", J Neurosurg, 80, pp.328~331 (1994)
  15. Kawaguchi S, "Characteristics of intracranial aneurysms associated with moyamoya disease : a review of 111 cases", Acta Neurochir(Wien), 138, pp.1287~1294 (1996)
  16. Kawai K, "Ventricular hemorrhage at an early stage of moyamoya disease—case report", Neurol Med Chir(Tokyo), 37, pp.184~187 (1997)
  17. Miyake H, "Intraventricular aneurysms—three case reports", Neurol Med Chir(Tokyo), 40, pp.55~60 (2000)
  18. Lee JK, "Distal anterior choroidal artery aneurysm in a patient with moyamoya disease : case report", Neurosurgery, 48, pp.222~225 (2001)
  19. Kuroda S, "Effects of surgical revascularization on peripheral artery aneurysms in moyamoya disease : report of three cases", Neurosurgery, 49, pp.463~467 (2001)
  20. Wong GK, "Ruptured distal anterior choroidal artery aneurysm presenting with right intracerebral haematoma : clipping aided by subpial uncal resection", J Clin Neurosci, 10, pp.689~691 (2003)
  21. Koebbe CJ, "A rare case of a ruptured middle meningeal aneurysm causing intracerebral hematoma in a patient with moyamoya disease", AJNR Am J Neuroradiol, 25, pp.574~576 (2004)
  22. Baik SK, "Endovascular management of peripheral lateral posterior choroidal artery aneurysm associated with moyamoya disease : case report and review of the literature", Neurointervention, 1, pp.44~49 (2006)
  23. Gandhi CD, "Treatment of ruptured lenticulostriate artery aneurysms", J Neurosurg, 109, pp.28~37 (2008)
  24. Choulakian A, "NBCA embolization of a ruptured intraventricular distal anterior choroidal artery aneurysm in a patient with moyamoya disease", J Neurointerv Surg, 2, pp.368~370 (2010)
  25. Park YS, "Repeated rupture of a middle meningeal artery aneurysm in moyamoya disease : case report", J Neurosurg, 113, pp.749~752 (2010)
  26. Leung GK, "Thalamo-perforating artery aneurysm in moyamoya disease–case report", Br J Neurosurg, 24, pp.479~481 (2010)
  27. Yang S, "Endovascular embolization of distal anterior choroidal artery aneurysms associated with moyamoya disease. A report of two cases and a literature review", Interv Neuroradiol, 16, pp.433~441 (2010)
  28. Yu JL, "Endovascular treatment of intracranial aneurysms associated with moyamoya disease or moyamoya syndrome", Interv Neuroradiol, 16, pp.240~248 (2010)
  29. Lévêque M, "Endoscopic treatment of distal choroidal artery aneurysm", J Neurosurg, 114, pp.116~119 (2011)
  30. Xu HW, "Two different methods of endovascular treatment for ruptured intracranial aneurysm associated with moyamoya disease and review of the literature", Life Sci J, 8, pp.386~389 (2011)
  31. Ni W, "Disappearance of aneurysms associated with moyamoya disease after STA-MCA anastomosis with encephaloduro myosynangiosis", J Clin Neurosci, 19, pp.485~487 (2012)
  32. Hayashi K, "A case of unilateral moyamoya disease suffered from intracerebral hemorrhage due to the rupture of cerebral aneurysm, which appeared seven years later", Surg Neurol Int, 4, pp.17~ (2013)
  33. Chalouhi N, "Onyx embolization of a ruptured lenticulostriate artery aneurysm in a patient with moyamoya disease", World Neurosurg, 80, pp.436~ (2013)
  34. Okamura K, "Ruptured basilar artery perforator aneurysm : a novel mechanism of pure subarachnoid hemorrhage in moyamoya disease. Illustrative case", J Neurosurg Case Lessons, 4, pp.CASE22238~ (2022)
  35. He K, "Management of distal choroidal artery aneurysms in patients with moyamoya disease : report of three cases and review of the literature", World J Surg Oncol, 11, pp.187~ (2013)
  36. Yuan Z, "Intraventricular aneurysms : case reports and review of the literature", Clin Neurol Neurosurg, 115, pp.57~64 (2013)
  37. Hwang K, "Endovascular embolization of a ruptured distal lenticulostriate artery aneurysm in patients with moyamoya disease", J Korean Neurosurg Soc, 56, pp.492~495 (2014)
  38. Daou B, "Onyx embolization of a ruptured aneurysm in a patient with moyamoya disease", J Clin Neurosci, 22, pp.1693~1696 (2015)
  39. Liu P, "Intracranial aneurysms associated with moyamoya disease in children : clinical features and long-term surgical outcome", World Neurosurg, 94, pp.513~520 (2016)
  40. Kim YS, "Ruptured choroidal artery aneurysms in patients with moyamoya disease : two case series and review of the literatures", J Clin Neurosci, 44, pp.236~239 (2017)
  41. Rhim JK, "Ruptured aneurysms of collateral vessels in adult onset moyamoya disease with hemorrhagic presentation", Clin Neuroradiol, 28, pp.191~199 (2018)
  42. Tokairin K, "Neuroendoscope-assisted aneurysm trapping for ruptured intraventricular aneurysms in moyamoya disease patients", World Neurosurg, 141, pp.278~283 (2020)
  43. Zhao X, "Treatment strategies of ruptured intracranial aneurysms associated with moyamoya disease", Br J Neurosurg, 35, pp.209~215 (2021)
  44. Larson A, "Intracranial aneurysms in white patients with moyamoya disease : a U. S. single-center case series and review", World Neurosurg, 138, pp.e749~e758 (2020)
  45. Goto Y, "Managing intervention for severe intraventricular hemorrhage casting in moyamoya disease : report of two cases", Int J Surg Case Rep, 73, pp.271~276 (2020)
  46. Byeon Y, "A ruptured lenticulostriate artery aneurysm in moyamoya disease treated with Onyx embolization", J Cerebrovasc Endovasc Neurosurg, 24, pp.154~159 (2022)
  47. Fu C, "Recurrent artery of heubner aneurysm masquerading as caudate hemorrhage without subarachnoid hemorrhage in moyamoya disease : a case report and literature review", Curr Med Imaging, 18, pp.429~431 (2022)
  48. Kusakabe T, "Disappearance of a moyamoya-related distal anterior cerebral artery aneurysm after target bypass revascularization : illustrative case", J Neurosurg Case Lessons, 6, pp.CASE23200~ (2023)
  49. Lee GY, "Hydration-induced rapid growth and regression after indirect revascularization of an anterior choroidal artery aneurysm associated with moyamoya disease : a case report", J Cerebrovasc Endovasc Neurosurg, 25, pp.75~80 (2023)
  50. Ding W, "Moyamoya disease with distal anterior choroidal artery aneurysm resected via transcallosal approach : a case report and review", Medicine(Baltimore), 102, pp.e33973~ (2023)
  51. Ando M, "Ruptured saccular aneurysm of the lenticulostriate artery embolized without parent artery occlusion in a case of moyamoya disease", Neuroradiol J, 36, pp.108~111 (2023)
  52. Funaki T, "Angiographic features of hemorrhagic moyamoya disease with high recurrence risk : a supplementary analysis of the Japan adult moyamoya trial", J Neurosurg, 128, pp.777~784 (2018)
  53. Fujimura M, "Intrinsic development of choroidal and thalamic collaterals in hemorrhagic-onset moyamoya disease : casecontrol study of the Japan adult moyamoya trial", J Neurosurg, 130, pp.1453~1459 (2019)
  54. Wiedmann MKH, "Treatment of ruptured aneurysms of the choroidal collateral system in moyamoya disease : a systematic review and data analysis", J Neurosurg, 136, pp.637~646 (2021)
  55. Sato Y, "Characteristics of moyamoya disease based on national registry data in Japan", Stroke, 50, pp.1973~1980 (2019)
  56. Ge P, "Clinical features, surgical treatment, and outcome of intracranial aneurysms associated with moyamoya disease", J Clin Neurosci, 80, pp.274~279 (2020)
  57. Saeki N, "Hemorrhagic type moyamoya disease", Clin Neurol Neurosurg, 99(Suppl 2), pp.S196~S201 (1997)
  58. Kobayashi E, "Long-term natural history of hemorrhagic moyamoya disease in 42 patients", J Neurosurg, 93, pp.976~980 (2000)
  59. Iwama T, "Mechanism of intracranial rebleeding in moyamoya disease", Clin Neurol Neurosurg, 99(Suppl 2), pp.S187~S190 (1997)
  60. Yan J, "Clinical features and prognostic analysis of moyamoya disease associated with intracranial aneurysms", Neurol Res, 42, pp.767~772 (2020)
  61. Eguchi H, "Aneurysm appearing at the anastomosis site 11 years after superficial temporal arterymiddle cerebral artery bypass surgery : moyamoya disease with a rapidly growing aneurysm. Illustrative case", J Neurosurg Case Lessons, 6, pp.CASE23529~ (2023)
  62. Kondo K, "Spontaneous occlusion of ruptured microaneurysm formed on postoperative transosseous anastomosis after indirect revascularization in a patient with moyamoya disease", Acta Neurochir(Wien), 166, pp.206~ (2024)
  63. Nishimoto T, "A ruptured middle cerebral artery aneurysm originating from the site of anastomosis 20 years after extracranial-intracranial bypass for moyamoya disease : case report", Surg Neurol, 64, pp.261~265 (2005)
  64. Eom KS, "Intracerebral hemorrhage caused by rupture of a giant aneurysm complicating superficial temporal artery-middle cerebral artery anastomosis for moyamoya disease", Acta Neurochir(Wien), 152, pp.1069~1073 (2010)
  65. Fukushima Y, "Repeated de novo aneurysm formation after anastomotic surgery : potential risk of genetic variant RNF213c. 14576G>A", Surg Neurol Int, 6, pp.41~ (2015)
  66. Yokota H, "De novo aneurysm associated with superficial temporal artery to middle cerebral artery bypass : report of two cases and review of literature", World Neurosurg, 92, pp.583~ (2016)
  67. Aburakawa D, "Navigation-guided clipping of a de novo aneurysm associated with superficial temporal artery-middle cerebral artery bypass combined with indirect pial synangiosis in a patient with moyamoya disease", Neurosurg Rev, 40, pp.517~521 (2017)
  68. Takahashi H, "Spontaneous resolution of post-delivery or post-abortion uterine artery pseudoaneurysm : a report of three cases", J Obstet Gynaecol Res, 42, pp.730~733 (2016)
  69. Muroya T, "Delayed formation of splenic pseudoaneurysm following nonoperative management in blunt splenic injury : multiinstitutional study in Osaka, Japan", J Trauma Acute Care Surg, 75, pp.417~420 (2013)

관련 논문AI추천

Clinical Features and Outcomes of Intracranial Aneurysm Associated with Moyamoya Disease김동석, 김성한, 김용배, 박근영, 박은경, 심규원, 이재환, 장창기, 정준호대한신경과학회 · Journal of Clinical Neurology2020 · 제16권 제4호Medical Management of Adult Moyamoya Disease: A Review and Relevant Cases With Ischemic EventsMiki Fujimura, Oh Young Bang대한뇌졸중학회 · 대한뇌졸중영문학회지2025 · 제27권 제1호Moyamoya Disease: Treatment and Outcomes김정은, 김택균, 오창완, 조원상, Jae Seung Bang대한뇌졸중학회 · 대한뇌졸중영문학회지2016 · 제18권 제1호Clinical Risk Factors Affecting Procedure-Related Major Neurological Complications in Unruptured Intracranial Aneurysms김용배, 서상현, 장이욱, 정준호, 주진양, 홍창기연세대학교의과대학 · Yonsei Medical Journal2015 · 제56권 제4호Arteriovenous Malformation with an Occlusive Feeding Artery Coexisting with Unilateral Moyamoya Disease김진호, 김후원, 안성환, 추인성대한신경과학회 · Journal of Clinical Neurology2010 · 제6권 제4호Feasibility and efficacy of coil embolization for middle cerebral artery aneurysms고준경, 이재일, 이태홍, 최창화, Chae Wook Huh, Jae Young Choi영남대학교 의과대학 · Journal of Yeungnam Medical Science2019 · 제36권 제3호

이 간행물의 다른 논문 (12건)

Patent Foramen Ovale and Other Cardiopathies as Causes of Embolic Stroke With Unknown SourceJong S. Kimpp. 349-359Ethnic Differences in the Safety and Efficacy of Tenecteplase Versus Alteplase for Acute Ischemic Stroke: A Systematic Review and Meta-AnalysisTeddy Wu, William Kok-Fai Kong, Benjamin Yong Qiang Tan, Vijay Kumar Sharma, Ching-Hui Sia, Jin Hean Koh, Claire Yi Jia Lim, Lucas Tze Peng Tan, Kian Keong Poh, Leonard Leong Litt Yeo, Andrew Fu Wah Hopp. 371-390Carbonated Beverage, Fruit Drink, and Water Consumption and Risk of Acute Stroke: the INTERSTROKE Case-Control StudyFernando Lanas, Danuta Ryglewicz, Catriona Reddin, Annika Rosengren, Salim Yusuf, Martin O’Donnell, Xingyu Wang, Anna Czlonkowska, Andrew Smyth, Graeme J. Hankey, Albertino Damasceno, Helle Klingenberg Iversen, Shahram Oveisgharan, Fawaz Alhussain, Peter Langhorne, Dennis Xavier, Patricio Lopez Jaramillo, Aytekin Oguz, Clodagh McDermottpp. 391-402Early Neurological Deterioration and Time to Start Dual Antiplatelet Therapy in Patients With Acute Mild-to-Moderate Ischemic Stroke: A Pre-Specified Post Hoc Analysis of the ATAMIS TrialHui-Sheng Chen, Zhi-Guo Yao, Yu Cui, Jian Zhangpp. 403-414Early Improvement in Interstitial Fluid Flow in Patients With Severe Carotid Stenosis After Angioplasty and StentingShih-Pin Chen, Kai-Wei Yu, Te-Ming Lin, Chao-Bao Luo, Feng-Chi Chang, Jiing-Feng Lirng, Chih-Ping Chung, I-Hui Lee, Chia-Hung Wupp. 415-424
원문 보기